<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00264030</url>
  </required_header>
  <id_info>
    <org_study_id>EC00-02</org_study_id>
    <nct_id>NCT00264030</nct_id>
  </id_info>
  <brief_title>Distal Protection Combined With PTCA in AMI Patients</brief_title>
  <acronym>DIPLOMAT</acronym>
  <official_title>Distal Protection Combined With PTCA in AMI Patients -- The DIPLOMAT Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cordis Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cordis Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to evaluate if use of the AngioGuard™ XP improves myocardial
      reperfusion after PTCA as assessed by ST segment resolution at the end of PTCA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, multicenter trial. Patients will be randomized either to
      be treated by PTCA only or in combination with the An-gioGuard™ XP device. The patients will
      be followed for six-months post-procedure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2002</start_date>
  <completion_date type="Actual">August 2004</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Absolute ST segment resolution.</measure>
    <time_frame>post-PTCA</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ST segment resolution (&gt; 50% decrease).</measure>
    <time_frame>pre- and post-PTCA</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TIMI Frame Count</measure>
    <time_frame>post PTCA</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite endpoint of slow flow, no reflow or distal embolization.</measure>
    <time_frame>at anytime</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regional wall motion index by echocardiography.</measure>
    <time_frame>discharge and 6 month follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical success evaluation; qualitative evaluation of device and delivery system characteristics.</measure>
    <time_frame>post-procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac function assessed by echocardiography.</measure>
    <time_frame>before discharge and at 6 month follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>PTCA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>PTCA with angioguard</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Angioguard distal protection device</intervention_name>
    <description>PTCA with the Angioguard distal protection device.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Cordis AngioGuard™ XP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PTCA</intervention_name>
    <description>PTCA</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute myocardial infarction &lt; 12 hours with ST segment elevation &gt; 2 mm in at least 2
             contiguous leads;

          -  Clinical indication of primary PTCA;

          -  De novo or restenotic lesions in native coronary vessel, single vessel treatment only;

          -  Target lesion stenosis is &gt; 80% (by visual estimation).

        Exclusion Criteria:

          -  Patient has unprotected left main coronary disease with &gt; 50% stenosis in case left
             coronary artery is treated;

          -  Patient has an ostial target lesion;

          -  Killip class &gt; 3.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thierry LEFEVRE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Tarnier-Cochin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut Cardiovasculaire Paris Sud</name>
      <address>
        <city>Massy</city>
        <zip>F - 91300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2005</study_first_submitted>
  <study_first_submitted_qc>December 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2005</study_first_posted>
  <last_update_submitted>January 4, 2008</last_update_submitted>
  <last_update_submitted_qc>January 4, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Hans-Peter Stoll - Director Clinical Affairs</name_title>
    <organization>Cordis</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

